
Cataract Kush (S-LAB, Synoptis Pharma, Tilray): lineage from LA Confidential and myrcene
Indica strain with documented lineage from LA Confidential and OG Kush, supplied to Polish pharmacies by three producers in four registered positions. The terpene profile is described by one source, led by myrcene.
| Strain card | Cataract Kush |
|---|---|
| Producers | S-LAB, Synoptis Pharma, Tilray (4 pharmacy positions) |
| Medical brand | the same as the producer |
| Alternative names | none |
| Category according to sources | indica |
| Leading terpene | myrcene |
| Other terpenes | humulene caryophyllene limonene linalool pinene |
| Lineage | established La Confidential × Og Kush |
| Source consistency | one source |
- Who supplies. 3 producers (S-LAB, Synoptis Pharma, Tilray) in 4 positions, which may differ in declaration and origin of the raw material.
- Profile. Leads with myrcene, alongside humulene, caryophyllene, limonene, linalool, pinene. We do not provide percentage shares, as sources calculate them against different totals.
- Origin. Established lineage, parents are La Confidential and Og Kush.
- What is missing. The profile describes one source, so there is nothing to compare it with.
What is Cataract Kush and where does this strain come from?
Cataract Kush is an indica strain developed by DNA Genetics from the cross of LA Confidential and OG Kush. The lineage is recorded in the SeedFinder database and is not based on assumption from the name. It reaches Polish pharmacies as dried flower in four registered positions, and its terpene profile is led by myrcene.
The lineage record is a declaration from the breeder, not a result of genetic testing performed on the material sold in pharmacies. This difference matters when reading the entire summary: the origin states what the strain was derived from, and does not determine how a specific batch of dried flower approved for sale in Poland will behave.
The second parent shows the boundary of this documentation. OG Kush appears in the lineage graph of this cluster as a broad family of style, not one identified plant, and it also reaches Polish pharmacies as a separate position without established origin. The offspring thus has documented parents, and one of those parents is not documented.
The name is not a hint here. The same component is shared by ten cultivars in this cluster, half of which have established origins, and half do not have any at all. Blood Orange Kush comes from a completely different pair of parents than the strain described here, although both names sound similar. The common word does not prove kinship in any direction.
Which producers supply Cataract Kush to Polish pharmacies?
Three. Cataract Kush is supplied by S-LAB, Synoptis Pharma, and Tilray, together in four registered positions, as Tilray has two versions differing in declared potency, while the other producers have one each. All four positions are described with the same set of terpenes, assigned to the strain name, although they come from three different facilities.
| Producer | Positions in the register | How the version differs |
|---|---|---|
| S-LAB | one | Weaker of the two potencies present in this cluster; at the time of data collection described as widely available. |
| Synoptis Pharma | one | The same, weaker potency as S-LAB; at the time of data collection marked as unavailable. |
| Tilray | two | The only producer with two potencies of this strain; the weaker described as widely available, the stronger as unavailable. |
The total declared THC content range is 16.2-24.2%. This range does not come from measurements taken in pharmacies or from the ranges of one producer. Cataract Kush appears in the list in positions from three different companies, and each declares its own nominal value, adding an allowable deviation of one-tenth up and down. Only these separate ranges, overlapping, make up one range. Providing a single number would promise precision that the approving document does not give.
An identical set of terpenes across all four positions does not mean that the dried flower from the three facilities smells the same. It means that the description comes from one entry assigned to the strain name, not from separate analyses of batches. Availability changes faster than this description, as it depends on the import cycle and the permits, which have their expiration dates. In the registered designation of the strain name, there is actually none: it contains the producer and the declared content, so it is not the trade name that defines the identity of the position in circulation. The current state is recorded in the list of available strains, updated separately from this text.
What does Cataract Kush smell and taste like?
- humulene humulene
- caryophyllene caryophyllene
- limonene limonene
- linalool linalool
- myrcene myrcene (leading in the pharmacy list)
- pinene pinene
Heavy and earthy, with a peppery finish. The only available source assigns the same set of sensations to all four pharmacy positions: woody, earthy, sweet, fruity, spicy, and herbal. The smell of the dried flower, however, depends on the batch, drying method, and storage conditions, so the strain description is a starting point, not a guarantee.
The set of terpenes explains part of these associations. Myrcene leans towards earthy and hoppy notes, caryophyllene brings pepper, limonene citrus, pinene resin, linalool floral tone, and humulene returns to hops.
What is missing from this description is the proportions. Shares of individual components may be provided in strain databases, but their sums for the same positions give one summary of 46 percent, another 73, and a third 83, so the denominator is different each time. A number without a known denominator looks like a measurement, although it is not, which is why only the composition stands here.
When vaporizing, the taste impression changes during the session. The first draws carry lighter, more citrusy and resinous notes, and the higher the setting and the longer the session lasts, the more earthy and peppery tones emerge, up to the impression of burning at the upper limit of the range, when only the heaviest components of the profile are leaving the chamber.
How long does it take for Cataract Kush to take effect and how long does the effect last?
Inhaled within a few minutes, orally much later. After vaporization, THC concentration in the blood peaks between the third and tenth minute, and the perceived effect weakens after two, at most four hours. The oral route delays the onset to half an hour, and sometimes up to an hour and a half.
These numbers describe THC administered inhaled or orally, not this strain. There is no published pharmacokinetic study measuring concentrations after dried flower sold under the name Cataract Kush, so the only fair solution is to provide ranges for the route of administration and state directly where they come from: from studies on the pharmacokinetics of cannabinoids in humans.
After inhalation, the substance bypasses the digestive tract and enters the blood from the lungs, so the onset is counted in minutes. The peak perceived effect occurs later than the peak concentration in the blood, usually 15 to 30 minutes after the session ends, and declines within 2 to 4 hours. Vaporization differs from smoking in the temperature of the process, not the absorption course.
The oral route proceeds differently, as absorption from the digestive tract is slow and incomplete, and the liver processes part of the dose into a derivative with its own activity. The onset usually occurs after 30 to 90 minutes, the peak after 2 to 4 hours, and the effect can last up to 8 hours. The variability between individuals is significantly greater with this route than with inhalation.
What is known and what is not known about the effects of Cataract Kush?
Not much. No published clinical study pertains to this strain by name. The evidence that can be cited here relates to myrcene, the leading component of its profile, and comes from studies on rodents. The description of relaxing effects comes from the strain database, not from measurement.
There are three studies on myrcene, and all concern mice.
| Study | Model and route of administration | What was shown |
|---|---|---|
| Rao VS et al., 1990 Journal of Pharmacy and Pharmacology PMID:1983154 |
rodent (mouse) | Myrcene (10-40 mg/kg) reduced pain responses in mice in hot plate and writhing tests induced by acetic acid; the effect was reversed by naloxone and yohimbine, indicating involvement of alpha2-adrenergic receptors and release of endogenous opioids. |
| do Vale TG et al., 2002 Phytomedicine PMID:12587690 |
rodent (mouse, intraperitoneal administration) | Myrcene administered intraperitoneally (100-200 mg/kg) reduced locomotor activity in mice in the open field test, prolonged sleep induced by pentobarbital (at 200 mg/kg about 2.6 times), and reduced the number of entries into the open arms of the elevated plus maze, which the authors described as a weak anxiogenic effect, not anxiolytic. |
| Wagner JK et al., 2024 NeuroSci PMID:39728677 |
rodent (mouse, vapor inhalation) | With short inhalations mimicking inhaled administration in humans, beta-myrcene acted anxiolytically in the elevated plus maze in female mice, and in males only with a single inhalation. Unlike linalool, myrcene did not produce a synergistic effect with cannabidiol in either sex. |
In humans, it has not been shown that myrcene alone alleviates insomnia at doses typical for inhalation of dried flower. The direction of the effect in rodents depends on the route of administration and sex: after intraperitoneal injection in 2002, a slightly anxiogenic effect was described, and after inhalation in 2024, an anxiolytic effect in females. These two results do not cancel each other out, they only show that the conclusion depends on conditions that no popular strain database provides.
The rest of what circulates about this strain has a different status. The designation of effects as relaxing comes from the strain database maintained by one source, and is neither a measurement nor a result of a study with a control group. The same entry provides a set of terpenes for all four pharmacy positions, so the consistency between them confirms nothing beyond the fact that they come from one note.
What side effects have been reported after Cataract Kush?
None attributed to this strain by name. Reports are collected for the medicinal product, and the product here is the dried flower of a specific producer with a specific content, not the cultivar itself. Therefore, no available source provides frequencies for Cataract Kush, and what can be listed pertains to the raw material and the route of administration.
Symptoms noted after cannabis dried flower in general are repeatable: dry mouth and throat, dizziness, increased heart rate, drowsiness, drop in blood pressure upon standing, and anxiety at higher doses. None of these positions can today be assigned a frequency for the described strain, as data is not collected by cultivar.
The difference between these two paragraphs is not a formality. The four positions of this strain come from three producers, so even if reports were to flow in, they would be spread across four separate records with different declared potencies. Attributing a symptom to the strain name would require data at the batch level, and no one publishes such data.
The conclusion for the reader is simple: the strain description does not replace the leaflet or a conversation with the prescribing doctor. Cannabis dried flower is a pharmaceutical raw material dispensed by prescription in the Rpw category, and the choice of dosage and method of administration is up to the prescribing physician.
At what temperature should Cataract Kush be vaporized?
There is no single correct temperature. Myrcene, which leads the profile of this strain, boils at 166.8 degrees Celsius at atmospheric pressure, but the other components of this set evaporate at different points, spread over a range of more than one hundred degrees. The setting of the vaporizer is not the temperature of the dried flower.
Boiling points in this cluster come from PubChem and not all can be compared with each other. For myrcene, pinene, limonene, linalool, and caryophyllene, the database provides measurements at atmospheric pressure: approximately 167, 156, 178, 196, and 258 degrees Celsius, respectively. For humulene, the only record is 99.5 degrees at 3 mmHg, which is a number from a different system that cannot be inserted into the same column.
The practical conclusion is more modest than the tables circulating on forums suggest. Since the components of this profile evaporate over a range of more than one hundred degrees, no single setting will extract them all at once. The lower part of the range releases lighter terpenes, while the upper adds heavier ones and releases cannabinoids more strongly, at the cost of a harsher sensation in the throat.
The third matter is purely technical. The number on the display describes the heating element or chamber, not the plant material inside, which can be noticeably cooler, depending on the design of the device and how packed the chamber is. A separate text on vaporizer settings breaks down this difference.
Which strains are related to Cataract Kush?
- Comparisons with this strain. Four comparisons of this cluster place it alongside other positions from the list: Beach Crasher, Galaxy Walker OG, Gorilla Glue, Island Sweet Skunk. The comparison analyzes composition and availability, not determining which strain is for whom.
None. Among the strains currently available in Polish pharmacies, this one has no siblings, although its origin has been established. The reason lies with the second parent: OG Kush is in this context a label for an entire family of style, not a single plant, so it does not define siblings.
An empty result with a known lineage is not a gap in the data. A parent listed as a landrace or as a broad family of style does not create siblings, as many different plants are hidden under such a label. Two cultivars sharing only such a label are not recognized as siblings because it is unknown whether they have a common ancestor.
In this cluster, OG Kush stands among the parents of two other strains: Galaxy Walker OG and Chemango Kush. None of them is a sister of the strain described. OG Kush itself reaches pharmacies as a separate position and has no established origin, which clearly shows how little the common name component carries.
There are four comparisons in which Cataract Kush stands next to another strain in this cluster: with Gorilla Glue, with Beach Crasher, with Galaxy Walker OG, and with Island Sweet Skunk. These are comparisons of profile and application, not declarations of kinship. Those looking for strains with similarly led profiles should look at the leading terpene, not the genealogy tree.
Frequently asked questions about Cataract Kush
Is Cataract Kush an indica strain?
Yes. Both sources describing this strain consistently classify it as indica, and the consistency pertains to the classification itself, not the profile composition.
How many producers supply Cataract Kush to Polish pharmacies?
Three: S-LAB, Synoptis Pharma, and Tilray. Together they are responsible for four registered positions, as Tilray has two versions with different declared potencies.
Does the terpene profile of Cataract Kush confirm more than one source?
No. The composition is described by one source, so there is nothing to compare it with or confirm it, and it should be read as such.
Does Cataract Kush have documented lineage?
Yes. It lists LA Confidential and OG Kush as parents, and the cross is attributed to DNA Genetics breeding. This is a declaration from the breeder, not a result of genetic testing.
Are there clinical studies on the Cataract Kush strain?
No. There is no published clinical study regarding this strain by name, and available studies on myrcene were conducted on rodents.
Can Cataract Kush dried flower be purchased without a prescription?
No. Cannabis dried flower falls under the Rpw category, meaning it is dispensed only by prescription from a licensed physician.
The material is for informational purposes and does not replace medical advice or the leaflet included with the packaging. Editorial text by the editorial team of ubucha.pl.







